According to the new paper, other models display similar patterns, with OpenAI's ChatGPT-4 taking slightly more steps to get ...

Against erasure, against distortion, and against frameworks that do not fit, Jews are reclaiming the right to define ...

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

OpenAI’s newest creation, the o3 model—billed as their “smartest and most capable to date”—rebelled against direct commands ...

The Organisation for Economic Co-operation and Development (OECD) has established a set of principles for trustworthy AI that ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...

After layoffs at Recursion, the company’s CEO writes about taking inspiration from an unexpected source: “The Art of Racing ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of ...

Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to ...

Recursion Pharmaceuticals said on Tuesday it will lay off around 20% of its workforce and focus on developing drugs for rare diseases and cancers to reduce cash burn during a prolonged biotech ...

We recently published a list of 10 Stocks Are Dominating Like Wall Street Titans. In this article, we are going to take a ...